Novo Nordisk launches obesity medicine Wegovy® (Semaglutide 2.4mg) (MAL24126014AZ) in Malaysia: A key advancement in the fight against non-communicable diseases
Novo Nordisk announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults overweight or living with obesity who present with at least one…
